首页> 外文期刊>Reproductive toxicology >Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats.
【24h】

Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats.

机译:pregnant曲毒素A的临界时期和最低单次口服剂量可诱导怀孕的Wistar大鼠发育毒性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Ochratoxin A (OTA), a potent in vivo teratogen, has been tested in various laboratory animal species. Present investigation was conducted to determine critical dose and critical time for the developmental toxicity of OTA in pregnant Wistar rats after single oral dose administration. OTA at different graded dose levels (2-4 mg/kg body weight) and at different gestation days (6-15), caused variable developmental defects in developing fetuses. OTA at 2.75 mg/kg body weight, dissolved in 0.1 M sodium bicarbonate (vehicle) and administered by oral intubation as a single dose on one of the gestational days 6-15, caused significant maternal toxicity in the dams and various gross, visceral and skeletal anomalies in the fetuses. The major gross malformations were external hydrocephaly, incomplete closure of skull and omphalocele. Internal hydrocephaly, microphthalmia, enlarged renal pelvis and renal hypoplasia were the main internal soft tissue anomalies. Major skeletal defects were developmental defects in skull bones, sternebrae, vertebrae and ribs. The gestational days 6 and 7 were found to be the most critical for the induction of teratogenicity in rats. Single oral dose of 2.75 mg/kg body weight OTA was found to be the minimum effective teratogenic dose in pregnant Wistar rats.
机译:ch曲霉毒素A(OTA)是一种有效的体内致畸剂,已在各种实验室动物物种中进行了测试。目前的研究是为了确定口服一次口服Wistar大鼠对OTA发育毒性的临界剂量和临界时间。不同分级剂量水平(2-4 mg / kg体重)和不同妊娠天数(6-15)的OTA会导致发育中的胎儿出现不同的发育缺陷。以2.75 mg / kg体重的OTA浓度溶解于0.1 M碳酸氢钠(载体)中,并在妊娠第6至15天之一通过口服插管单次给药,对大坝以及各种毛重,内脏和腹部的母亲产生了明显的毒性。胎儿的骨骼异常。主要的严重畸形是外部脑积水,头骨闭合不全和食管膨出。内部脑积水,小眼症,肾盂增大和肾发育不全是主要的内部软组织异常。主要的骨骼缺陷是颅骨,胸骨,椎骨和肋骨的发育缺陷。发现妊娠第6天和第7天对大鼠致畸性的诱导最为关键。发现口服2.75 mg / kg体重的OTA剂量是怀孕的Wistar大鼠的最小有效致畸剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号